I am not normally a big supporter of weed stocks. However, MDRM is different in my opinion because their stated direction is the homeopathic market, they will sell their product in drug stores, and they are actively pursuing a pill form that will convey the benefits of marijuana without the hallucinatory side effects. The fact that they are being backed by fund with enormous financial backing is a real plus. I can see this stock going to a dime in short order, and from there who knows. A quarter, fifty cents, and even a dollar is very possible in the weeks ahead. For those who are not in our portfolio, put MDRM on your radar. You just might thank me later.
I am not normally a big supporter of weed stocks.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
AMN Healthcare Secures $400 Million in Senior Notes Offering
AMN Healthcare Secures $400 Million in Senior Notes Offering DALLAS — AMN Healthcare Services, Inc. (NYSE: AMN) has revealed a significant new financial maneuver. Its subsidiary, AMN Healthcare, Inc., has priced an impressive $400 million private offering of senior unsecured notes set to mature in 2031. Carrying a competitive interest rate of 6.500% per year, these...
Continue Reading
What's Ahead: Key Insights on the Upcoming UK Budget
Understanding the Context of the UK Budget As the UK prepares for a significant Budget presentation, Chancellor Rachel Reeves is set to outline pivotal changes that could affect various sectors. With the Labour government at the helm, UBS analysts highlight essential factors investors should monitor closely. Fiscal Challenges Ahead Currently, the government faces...
Continue Reading
Filament Health and UCL Launch Pivotal Phase 2 Trials
Exciting Phase 2 Research Trials Announced Filament Health Corp. (FLHLF), a leader in the development of natural psychedelic drugs, has recently announced an exciting collaboration with University College London (UCL). The partnership will focus on two pivotal Phase 2 research trials investigating the potential of PEX010, their botanical psilocybin drug, which aims to...
Continue Reading
Embrace Mindfulness This Holiday Season with Cotton & Melissa Wood
Celebrate Mindfulness This Holiday Season with Cotton Cotton Incorporated has joined forces with Melissa Wood-Tepperberg, the visionary behind Melissa Wood Health, to promote a lifestyle centered around mindfulness and intentional living. As the holiday season approaches, this collaboration is a reminder for all of us to slow down and reconnect with what truly matters....
Continue Reading
Exploring the Surge in Decorative Lighting Innovations
The decorative lighting market had a lot of buzz back in the day, projected to grow significantly—USD 8.65 billion from 2024 to 2028 with a CAGR over 4.52%. But those figures? They don't come easy, especially when you peel back the layers and see what's really going on. Drivers of Growth: Tech and Trends Smart lighting systems were one of the big players pushing this...
Continue Reading